NEW DELHI: Drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has slashed prices of more than 40 medicines , including those to treat cancer, HIV and blood clots, in its latest price notification. This round of price caps has resulted in a reduction of Rs 20 crore, according to the body.NPPA has capped prices of nine scheduled drugs and revised the prices of 34. It has also fixed the prices of 11 retail formulations, including Zydus Cadila's Zyrop injections. For instance, the price of Zyrop 20000—used to treat anemia due to chemotherapy and anemia due to chronic kidney disease—is fixed at Rs4,925.59 for a pack.Imatinib (400mg), used to treat some types of cancers and blood diseases, is now capped at Rs236.99 per capsule, while fertility medicine chlomiphene (100mg) has been fixed at Rs51.64 for a pill. HIV/AIDS drug efavirenz (200mg) now costs Rs20.17 per tablet.NPPA has also slashed by nearly 30% the price of streptokinase (15,00,000 IU)—an essential medicine used immediately after heart attacks to dissolve blood clots in blood vessels. The injection's ceiling price is now capped at Rs1660.84 from Rs2245.83 in the National List of Essential Medicines (NLEM) 2011.Some popular streptokinase brands for this strength include Abbott Healthcare's Icikinase, Bharat Serums and Vaccines' Rthrombo, Cadila Pharmaceuticals' Stpase and Lupin's Lupiflo.NPPA has capped and revised the prices of 540 medicines in the last seven months, according the body. This has resulted in Rs2,300 crore reduction in prices of medicines in NLEM 2015, a senior government official told ET.